InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by Yared Nadim, Chairman & CEO. Director active across 1 company, notably CVRx, Inc.. Aggregated, 9 reports have been published. Activity tracked since 22 November 2021. The latest transaction was disclosed on 25 April 2022 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Declarations9 total
6,059 shares@ US$0.2370.0007% mcap16.7% of flowCommon StockSEC:0001415889-22-004278:0
2,659 shares@ US$0.2370.0003% mcap7.0% of flowCommon StockSEC:0001179110-22-000882:0
2,659 shares@ US$0.2370.0003% mcap16.7% of flowCommon StockSEC:0001179110-22-000882
10,500 shares0Common StockSEC:0001179110-22-000544
10,500 shares0Common StockSEC:0001179110-22-000544:0
2,080 shares@ US$0.2370.0002% mcap5.4% of flowCommon StockSEC:0001179110-21-011273:0
2,080 shares@ US$0.2370.0002% mcap13.0% of flowCommon StockSEC:0001179110-21-011273
11,006 shares@ US$0.240.0013% mcap29.2% of flowCommon StockSEC:0001179110-21-010375:0
11,006 shares@ US$0.240.0013% mcap70.2% of flowCommon StockSEC:0001179110-21-010375
9 of 9 declarations
About Yared Nadim
Nadim Yared is the Chief Executive Officer of CVRx, Inc. As CEO, he leads the company in developing innovative medical solutions. CVRx, Inc. specializes in technologies for treating cardiovascular diseases. Yared is responsible for the overall strategy and innovation within the company.
